NASDAQ:TCRX | Operating Income | TScan Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$30.49M
2026-03-31-$29.14M
2025-12-31-$23.86M
2025-09-30-$37.05M
2025-06-30-$38.65M
2025-03-31-$36.25M
2024-12-31-$36.71M
2024-09-30-$32.62M
2024-06-30-$34.11M
2024-03-31-$31.37M
2023-12-31-$21.36M
2023-09-30-$24.75M
2023-06-30-$24.61M
2023-03-31-$22.74M
2022-12-31-$18.65M
2022-09-30-$16.58M
2022-06-30-$15.25M
2022-03-31-$16.16M
2021-12-31-$14.2M
2021-09-30-$15.84M
2021-06-30-$10.68M
2021-03-31-$7.92M
2020-12-31-$7.81M
2020-09-30-$7.17M
2020-06-30-$5.62M

Annual Operating Income

DateOperating Income
2025-12-31-$135.81M
2024-12-31-$134.82M
2023-12-31-$93.46M
2022-12-31-$66.64M
2021-12-31-$48.64M
2020-12-31-$26.23M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.